Emerging roles for high-density lipoproteins in neurodegenerative disorders
MetadataShow full item record
Lipoproteins are the complexes of different lipids and proteins, which are devoted to the transport and clearance of lipids or lipid-related molecules in the circulation. Lipoproteins have been found to play a crucial role in brain function and may influence myelination process. Among lipoproteins, high-density lipoproteins (HDLs) and their major protein component, apoA-I, are directly involved in cholesterol efflux in the brain. It has been suggested that inadequate or dysfunctional brain HDLs may contribute to cerebrovascular dysfunctions, neurodegeneration, or neurovascular instability. HDL deficiency could also promote cognitive decline through impacting on atherosclerotic risk. The focus of this review is to discuss knowledge on HDL dysregulation in neurological disorders. A better understanding on how changes in cellular HDL and apolipoprotein homeostasis affect central nervous system function may provide promising novel avenues for the treatment of specific HDL-related neurological disorders. © 2019 International Union of Biochemistry and Molecular Biology
Showing items related by title, author, creator and subject.
ReviewBinvignat O.; Olloquequi J. (Bentham Science Publishers, 2020)
APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis (2020) Uddin M.S.; Kabir M.T.; Al Mamun A.; Abdel-Daim M.M.; Barreto G.E.; Ashraf G.M. (Humana Press Inc., 2019)
ReviewMomtazi-Borojeni A.A.; Sabouri-Rad S.; Gotto A.M.; Pirro M.; Banach M.; Awan Z.; Barreto G.E.; Sahebkar A. (Oxford University Press, 2019)